PT1119344E - Metodo de prevencao e/ou de tratamento cosmetico das estrias da pele e utilizacao em dermatologia - Google Patents

Metodo de prevencao e/ou de tratamento cosmetico das estrias da pele e utilizacao em dermatologia

Info

Publication number
PT1119344E
PT1119344E PT99970017T PT99970017T PT1119344E PT 1119344 E PT1119344 E PT 1119344E PT 99970017 T PT99970017 T PT 99970017T PT 99970017 T PT99970017 T PT 99970017T PT 1119344 E PT1119344 E PT 1119344E
Authority
PT
Portugal
Prior art keywords
striae
skin
dermatology
prevention
cosmetic treatment
Prior art date
Application number
PT99970017T
Other languages
English (en)
Inventor
Philippe Msika
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Publication of PT1119344E publication Critical patent/PT1119344E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT99970017T 1998-10-05 1999-10-05 Metodo de prevencao e/ou de tratamento cosmetico das estrias da pele e utilizacao em dermatologia PT1119344E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812435A FR2784029B1 (fr) 1998-10-05 1998-10-05 Methode de prevention et/ou de traitement cosmetique des vergetures de la peau et utilisation en dermatologie

Publications (1)

Publication Number Publication Date
PT1119344E true PT1119344E (pt) 2005-05-31

Family

ID=9531192

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99970017T PT1119344E (pt) 1998-10-05 1999-10-05 Metodo de prevencao e/ou de tratamento cosmetico das estrias da pele e utilizacao em dermatologia

Country Status (13)

Country Link
EP (1) EP1119344B1 (pt)
KR (1) KR100568007B1 (pt)
AT (1) ATE285224T1 (pt)
AU (1) AU5989499A (pt)
CA (1) CA2346384C (pt)
DE (1) DE69922819T2 (pt)
ES (1) ES2234336T3 (pt)
FR (1) FR2784029B1 (pt)
HK (1) HK1039271A1 (pt)
MX (1) MXPA01003518A (pt)
PL (1) PL347095A1 (pt)
PT (1) PT1119344E (pt)
WO (1) WO2000019974A1 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802413B1 (fr) * 1999-12-17 2003-10-31 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
FR2811892B1 (fr) * 2000-07-18 2003-04-18 Oreal Composition comprenant un extrait de sophora japonica et utilisation
WO2002049656A1 (fr) * 2000-12-19 2002-06-27 Kabushiki Kaisha Yakult Honsha Preparations externes pour la peau et leur procede de production
FR2825918B1 (fr) * 2001-06-14 2005-01-21 Alfred Denner Procede cosmetique du traitement des vergetures
FR2827170B1 (fr) 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
ITMI20020147A1 (it) 2002-01-29 2003-07-29 Indena Spa Estrazione purificazione e modificazione di polipeptidi da seme di soia
FR2856294B1 (fr) 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
WO2005048968A1 (en) * 2003-11-17 2005-06-02 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
KR100656807B1 (ko) * 2005-02-23 2006-12-13 배석년 구연산, 아연 및 아르기닌으로 이루어진 팽창선조 예방 및치료용 조성물
JP2008074788A (ja) * 2006-09-22 2008-04-03 Rohto Pharmaceut Co Ltd エラスチン産生促進剤
KR100846356B1 (ko) * 2007-11-27 2008-07-15 신라대학교 산학협력단 파래 속 추출물을 포함하는 항진균 조성물
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
FR2939039B1 (fr) 2008-12-01 2010-12-31 Basf Beauty Care Solutions France Sas Nouvel agent inhibiteur de secretion de sebum
FR2954702B1 (fr) 2009-12-31 2013-07-05 Basf Beauty Care Solutions F Agent stimulant l'expression de loxl
FR2973246B1 (fr) 2011-03-31 2013-04-12 Nuxe Lab Composition a base de camellia japonica pour la protection de la peau.
FR2977797B1 (fr) 2011-07-13 2014-01-17 Urgo Lab Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures
FR2994387B1 (fr) 2012-08-13 2016-07-29 Basf Beauty Care Solutions France Sas Ingredient hydratant cosmetique ou pharmaceutique
FR3003758B1 (fr) 2013-03-27 2015-07-17 Basf Beauty Care Solutions France Sas Utilisation cosmetique ou dermatologique d'un extrait de polygonum bistorta
FR3010314B1 (fr) 2013-09-12 2017-05-05 Basf Beauty Care Solutions France Sas Utilisation cosmetique ou dermatologique d'un extrait de tapirira guyanensis
FR3030275B1 (fr) 2014-12-23 2018-03-02 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de lythrum salicaria
FR3049859B1 (fr) 2016-04-12 2023-11-03 Basf Beauty Care Solutions France Sas Utilisation cosmetique d'un extrait de khaya senegalensis
FR3055799B1 (fr) 2016-09-15 2020-06-19 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmetique et/ou nutraceutique ou dermatologique d'un extrait de levure
FR3058641B1 (fr) 2016-11-17 2019-11-01 Basf Beauty Care Solutions France Sas Utilisation cosmetique, nutraceutique ou pharmaceutique preferentiellement dermatologique d'un extrait de feuilles de la plante lansium domesticum pour diminuer la pigmentation de la peau et/ou des annexes cutanees
FR3061015B1 (fr) 2016-12-23 2019-09-20 Basf Beauty Care Solutions France Sas Utilisation cosmetique d'un extrait de corchorus olitorius
FR3065876B1 (fr) 2017-05-05 2020-08-14 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de nephelium lappaceum pour augmenter la fermete de la peau et/ou des muqueuses
FR3069162A1 (fr) 2017-07-24 2019-01-25 Basf Beauty Care Solutions France Sas Extrait aqueux de momordica cochinchinensis pour maintenir et/ou augmenter l'expression des kindlines de la peau et des muqueuses
FR3097127B1 (fr) 2017-10-03 2022-09-16 Basf Beauty Care Solutions France Sas Procédé d’utilisation d’un inhibiteur de Let-7b en cosmétique et/ou en nutraceutique
FR3071742B1 (fr) 2017-10-03 2020-07-10 Basf Beauty Care Solutions France Sas Procede d'utilisation d'un inhibiteur de let-7b en cosmetique et/ou en nutraceutique
FR3082122B1 (fr) 2018-06-11 2021-01-01 Basf Beauty Care Solutions France Sas Utilisation d'un extrait de bixa orellana
FR3085839A1 (fr) 2018-09-13 2020-03-20 Basf Beauty Care Solutions France Sas Utilisation de phytosterols
FR3092493A1 (fr) 2019-02-12 2020-08-14 Dermaconcept Jmc Composition cosmétique et/ou dermatologique pour lutter contre les vergetures
FR3093644B1 (fr) 2019-03-12 2021-07-02 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmétique de sphères poreuses d’oxyde métallique
FR3098405B1 (fr) 2019-07-12 2021-06-25 Expanscience Lab Composition comprenant des polyphénols de graines de passiflore, des peptides d’avocat et un extrait d’hamamélis et utilisation pour traiter et/ou prévenir les vergetures
FR3099702B1 (fr) 2019-08-08 2022-03-25 BASF Beauty Care Solutions FR Nouvelle utilisation cosmétique d’un extrait d’Epilobium angustifolium
FR3099701B1 (fr) 2019-08-08 2022-03-25 BASF Beauty Care Solutions FR Nouvelle utilisation cosmétique d’une combinaison d’oenothéine-B et de quercétine-3-O-glucuronide
FR3125967A1 (fr) 2021-08-06 2023-02-10 Basf Beauty Care Solutions France Sas Utilisations cosmétiques contre la lumière bleue de microsphères poreuses d’oxyde métallique
FR3131838A1 (fr) 2022-01-18 2023-07-21 Basf Beauty Care Solutions France Sas Nouvelle utilisation cosmétique de sphères poreuses à porosité fermée d’oxyde métallique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444091A (en) * 1994-05-24 1995-08-22 Dermatology Home Products, Inc. Method of applying alpha hydroxy acids for treating striae distensae
US5759555A (en) * 1996-06-07 1998-06-02 Moy; Lawrence S. Cosmetic formulation and method for amelioration of skin keratoses and striae distensae

Also Published As

Publication number Publication date
EP1119344B1 (fr) 2004-12-22
WO2000019974A1 (fr) 2000-04-13
FR2784029B1 (fr) 2001-01-05
MXPA01003518A (es) 2002-09-18
ES2234336T3 (es) 2005-06-16
DE69922819T2 (de) 2005-12-22
ATE285224T1 (de) 2005-01-15
PL347095A1 (en) 2002-03-25
CA2346384C (fr) 2011-07-12
DE69922819D1 (de) 2005-01-27
KR20010079997A (ko) 2001-08-22
KR100568007B1 (ko) 2006-04-07
FR2784029A1 (fr) 2000-04-07
AU5989499A (en) 2000-04-26
EP1119344A1 (fr) 2001-08-01
HK1039271A1 (en) 2002-04-19
CA2346384A1 (fr) 2000-04-13

Similar Documents

Publication Publication Date Title
PT1119344E (pt) Metodo de prevencao e/ou de tratamento cosmetico das estrias da pele e utilizacao em dermatologia
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
ES2178000T3 (es) Composiciones y metodos para tratar infecciones usando analogos de indolicidina.
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
ATE284959T1 (de) Unterbrechung der bindung der proteine mdm2 und p53 und entsprechende therapeutische anwendung
TW200509956A (en) Compositions and methods for treatment of rosacea
CA2178728A1 (en) Skin tanning compositions
ES2130868T3 (es) Utilizacion de un extracto de al menos una iridacea en el tratamiento de las arrugas.
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
DK1059934T3 (da) Matrixproteinpræparater til sårheling
TW200505473A (en) Compositions and methods for treatment of psoriasis
ES2103145T3 (es) Composicion para el tratamiento y la proteccion de los cabellos, pestañas y cejas a base de ceramidas y de polimeros de vinilpirrolidona.
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
BRPI0408948A (pt) composição de aplicação tópica para a prevenção e tratamento de celulite
IL101675A0 (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
EP0728468A3 (en) Cosmetic compositions for treating itchy skin
ATE235249T1 (de) Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen
BR9708037A (pt) Método para o tratamento de abuso de substância
BR9808216B1 (pt) composição farmacêutica ou cosmética compreendendo retinóide com melibiose, uso da mesma e método para o tratamento cosmético de alterações associadas com o envelhecimento da pele e/ou o exoesqueleto.
NO984198L (no) FremgangsmÕte for behandling av aggresjon
DE69800906D1 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie